Correction to: J Headache Pain (2019) 20:37
https://doi.org/10.1186/s10194-019-0974-3
Anzeige
After publication of the original article [1], the authors have notified us that the row corresponding to the “Alniditan” drug shouldn’t have been included in Table 1. Table 1 should therefore be presented as below:
Table 1
Overview of ditans in alphabetical order
Drug | Status |
|---|---|
Lasmiditan (COL-144) | Phase III clinical trials |
LY-334370 | Development terminated |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.